Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab plus methotrexate versus methotrexate alone in methotrexate-naive psoriatic arthritis
2012-005214-19Phase 3Completed
- Sponsor
- Academic Medical Center
- Start
- Jun 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in psoriatic arthritis (PsA) comparing Golimumab plus methotrexate with Methotrexate plus placebo (2 arms). Primary endpoint: Safety. Started Jun 2013; status: completed.
02
Drugs
golimumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2012-005214-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005214-19.